Effects of smoking on visual acuity of central serous chorioretinopathy patients

Basit Öğe Kaydı
dc.contributor.authorTurkcu, Fatih Mehmet
dc.contributor.authorYuksel, Harun
dc.contributor.authorSahin, Alparslan
dc.contributor.authorCinar, Yasin
dc.contributor.authorCingu, Kursat
dc.contributor.authorAri, Seyhmus
dc.contributor.authorSahin, Muhammed
dc.date.accessioned2024-04-24T17:20:35Z
dc.date.available2024-04-24T17:20:35Z
dc.date.issued2014
dc.departmentDicle Üniversitesien_US
dc.description.abstractBackground: The aim of this study was to evaluate the differences, in terms of visual outcome and treatment needs, between smokers and non-smokers central serous chorioretinopathy (CSCR) patients. Methods: The files of 252 patients diagnosed with CSCR who had presented to the Retina Unit of the Ophthalmology Clinic at Dicle University Medical School in Turkey were retrospectively evaluated. Eighty-four smokers, with a known history of smoking of at least one pack-year, and 133 non-smokers were included, whereas 35 patients with additional pathologies were excluded from the study. Results: Of the patients, 192 (88.5%) were male and 25 (11.5%) were female. The mean patient age was 38.8 +/- 8.1 years (range: 20-68 years). Visual acuity (VA) of the smoker and non-smoker groups was measured as 0.45 +/- 0.35 and 0.24 +/- 0.28 logarithm of the minimum angle of resolution (logMar), respectively, at the first visit; 0.19 +/- 0.29 and 0.06 +/- 0.14 logMar at the sixth month; and 0.07 +/- 0.14 and 0.02 +/- 0.05 logMar at the ninth month. VA measurements at presentation and during all examinations (1th, 6th and 9th month) were significantly different for the two groups. VA was lower in the smoker group. In 27 patients (12.4%), an additional treatment modality was needed. Of the 27 patients, only 8 (6%) were non-smokers, whereas 19 (22.6%) were smokers. There was no difference between groups in the recurrence rate during follow-up (p = 0.907); 14 (16.7%) smokers and 8 (19.0%) non-smokers experienced a recurrence. Conclusion: This study has shown that patients selected and who are current smokers have poorer vision and need longer treatment.en_US
dc.description.sponsorshipDicle University DUBAPen_US
dc.description.sponsorshipThis submission has not been published anywhere previously and is not simultaneously being considered for any other publication. The authors report no declarations of interest. We are grateful to Dicle University DUBAP for their sponsorship about English editing of this manuscript.en_US
dc.identifier.doi10.3109/15569527.2013.810633
dc.identifier.endpage119en_US
dc.identifier.issn1556-9527
dc.identifier.issn1556-9535
dc.identifier.issue2en_US
dc.identifier.pmid23841829
dc.identifier.scopus2-s2.0-84901310208
dc.identifier.scopusqualityQ3
dc.identifier.startpage115en_US
dc.identifier.urihttps://doi.org/10.3109/15569527.2013.810633
dc.identifier.urihttps://hdl.handle.net/11468/19147
dc.identifier.volume33en_US
dc.identifier.wosWOS:000336731700007
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherInforma Healthcareen_US
dc.relation.ispartofCutaneous and Ocular Toxicology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCentral Serous Chorioretinopathyen_US
dc.subjectCigaretteen_US
dc.subjectSmokingen_US
dc.titleEffects of smoking on visual acuity of central serous chorioretinopathy patientsen_US
dc.titleEffects of smoking on visual acuity of central serous chorioretinopathy patients
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu